Binding of organometallic ruthenium(II) anticancer compounds to nucleobases: A computational study

Journal of Physical Chemistry A

Volumn 113, Issue 43, 2009, Pages 11888-11897

  Gossens, Christian ^a   Tavernelli, Ivano ^a   Rothlisberger, Ursula ^a  

^a EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO GROUP; ANTICANCER COMPOUNDS; AQUA LIGANDS; COMPUTATIONAL STUDIES; DOUBLE STRANDED DNA; ETHYLENE DIAMINE; GASPHASE; LEAVING GROUPS; LIGAND EXCHANGE REACTIONS; NUCLEOBASES; NUCLEOPHILIC CENTERS; REACTION PATHWAYS; RECOGNITION PATTERNS; THERMALLY STABLE; TRANSITION STATE;

ACTIVATION ENERGY; AMINES; ATOMS; BENZENE; CHEMICAL REACTIONS; DNA; GENES; HYDROGEN; LIGANDS; NUCLEIC ACIDS; ORGANOMETALLICS; RUTHENIUM;

POSITIVE IONS;

ANTINEOPLASTIC AGENT; DNA; LIGAND; ORGANOMETALLIC COMPOUND; PROTON; RUTHENIUM; SOLVENT;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; CONFORMATION; GAS; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; QUANTUM THEORY;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; COMPUTER SIMULATION; DNA; GASES; LIGANDS; MODELS, MOLECULAR; NUCLEIC ACID CONFORMATION; ORGANOMETALLIC COMPOUNDS; PROTONS; QUANTUM THEORY; RUTHENIUM; SOLVENTS;

EID: 70350398134     PISSN: 10895639     EISSN: None     Source Type: Journal    
DOI: 10.1021/jp903237w     Document Type: Article

References (53)

1. Rosenberg, B.; Camp, L. v.; Krigas, T. Nature 1965, 205, 698-699.
2. Reedijk, J. Chem. Commun. 1996, 801-806.
3. Wong, E.; Giandomenico, C. M. Chem. Rev. 1999, 99, 2451-2466.
4. Fuertes, M. A.; Alonso, C.; Pérez, J. M. Chem. Rev. 2003, 103, 645-662.
5. Clarke, M. J.; Zhu, F.; Frasca, D. R. Chem. Rev. 1999, 99, 2511-2533.
6. Galanski, M.; Arion, V. B.; Jakupec, M. A.; Keppler, B. K. Curr. Pharm. Des. 2003, 9, 2078-2089.
7. Haiduc, I.; Silvestru, C. Coord. Chem. Rev. 1990, 99, 253-296
8. Guo, Z.; Sadler, P. J. Angew. Chem., Int. Ed. Engl, 1999, 38, 1512-1531.
9. Wang, D.; Lippard, S. J. Nature Rev. Drug Discovery 2005, 4, 307-320.
10. Allardyce, C. S.; Dyson, P. J. Platinum Metals. Rev. 2001, 45, 62-69.
11. Sava, G.; Capozzi, I.; Clerici, K.; Gagliardi, G.; Alessio, E.; Mestroni, G. Clin. Exp. Met. 1998, 16, 371-379.
12. Rademaker-Lakhai Jeany, M.; van den Bongard, D.; Pluim, D.; Beijnen Jos, H.; Schellens Jan, H. M. Clin. Cancer Res. 2004, 10, 3717-3727
13. Kapitza, S.; Pongratz, M.; Jakupec, M. A.; Heffeter, P.; Berger, W.; Lackinger, L.; Keppler, B. K.; Marian, B. J. Cancer Res. Clin. Oncol. 2005, 131, 101-110.
14. Hartinger, C. G.; Zorbas-Seifried, S.; Jakupec, M. A.; Kynast, B.; Zorbas, H.; Keppler, B. K. J. Inorg. Biochem. 2006, 100, 891.
15. Dyson, P. J.; Sava, G. Dalton Trans. 2006, 1929-1933.
16. Yan Yaw, K.; Melchart, M.; Habtemariam, A.; Sadler, P. J. Chem. Commun. 2005, 476, 4-76.
17. Allardyce, C. S.; Dyson, P. J.; Ellis, D. J.; Heath, S. L. Chem. Commun. 2001, 1396-1397.
18. Wang, F.; Habtemariam, A.; van der Geer, E. P. L.; Fernandez, R.; Melchart, M.; Deeth, R. J.; Aird, R.; Guichard, S.; Fabbiani, F. P. A.; Lozano-Casal, P.; Oswald, I. D. H.; Jodrell, D. I.; Parsons, S.; Sadler, P. J. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 18269-18274.
19. Scolaro, C.; Bergamo, A.; Brescacin, L.; Delfino, R.; Cocchietto, M.; Laurenczy, G.; Geldbach, T. J.; Sava, G.; Dyson, P. J. J. Med. Chem. 2005, 48, 4161-4171.
20. Gopal, Y. N. V.; Jayaraju, D.; Kondapi, A. K. Biochemistry 1999, 38, 4382-4388.
21. Gaiddon, C.; Jeannequin, P.; Bischoff, P.; Pfeffer, M.; Sirlin, C.; Loeffler, J. P. J. Pharmacol. Exp. Ther. 2005, 315, 1403-1411.
22. Huxham, L. A.; Cheu, E. L. S.; Patrick, B. O.; James, B. R. Inorg. Chem. Acta 2003, 352, 238-246.
23. Akbayeva, D. N.; Gonsalvi, L.; Oberhauser, W.; Peruzzini, M.; Vizza, F.; Brueggeller, P.; Romerosa, A.; Sava, G.; Bergamo, A. Chem. Commun. 2003, 264-265.
24. Romerosa, A.; Campos-Malpartida, T.; Lidrissi, C.; Saoud, M.; Serrano-Ruiz, M.; Peruzzini, M.; Gamdo-Cardenas, J. A.; Garcia-Maroto, F. Inorg. Chem. 2006, 45, 1289-1298.
25. Serli, B.; Zangrando, E.; Gianferrara, T.; Scolaro, C.; Dyson, P. J.; Bergamo, A.; Alessio, E. Eur. J. Inorg. Chem. 2005, 342, 3-3434.
26. Aird, R. E.; Cummings, J.; Ritchie, A. A.; Muir, M.; Morris, R. E.; Chen, H.; Sadler, P. J.; Jodrell, D. I Br. J. Cancer 2002, 86, 1652-1657.
27. Habtemariam, A.; Sadler, P. J., 2005-GB3242, 2006018649, 20050819, 2006.
28. Wang, F.; Chen, H.; Parsons, S.; Oswald, I. D. H.; Davidson, J. E.; Sadler, P. J. Chem.-Eur. J. 2003, 9, 5810-5820.
29. Wang, F.; Bella, J.; Parkinson, J. A.; Sadler, P. J. J. Biol. Inorg. Chem. 2005, 10, 147-155.
30. Wang, F.; Xu, J.; Habtemariam, A.; Bella, J.; Sadler Peter, J. J. Am. Chem. Soc. 2005, 127, 17734-17743
31. Chen, H.; Parkinson, J. A.; Parsons, S.; Coxall, R. A.; Gould, R. O.; Sadler, P. J. J. Am. Chem. Soc. 2002, 124, 3064-3082.
32. Chen, H.; Parkinson, J. A.; Morris, R. E.; Sadler, P. J. J. Am. Chem. Soc. 2003, 125, 173-186.
33. Gossens, C.; Tavernelli, I.; Rothlisberger, U. J. Chem. Theory Comp. 2007, 3, 1212-1222.
34. Dorcier, A.; Dyson, P. J.; Gossens, C.; Rothlisberger, U.; Scopelliti, R.; Tavernelli, I. Oreanometallics 2005, 24, 2114-2123.
35. Scolaro, C.; Geldbach, T. J.; Rochat, S.; Dorcier, A.; Gossens, C.; Bergamo, A.; Cocchietto, M.; Tavernelli, I.; Sava, G.; Rothlisberger, U.; Dyson, P. J. Organometallics 2006, 25, 756-765.
36. ADF 2004.01; SCM, Theoretical Chemistry; Vrije Universiteit: Amsterdam, The Netherlands, 2004; http://www.scm.com.
37. Becke, A. D. Phys. Rev. A 1988, 38, 3098-3100
38. Perdew, J. P. Phys. Rev. B 1986, 33, 8822-8824.
39. Lenthe, E. v.; Ehlers, A. E.; Baerends, E. J. J. Chem. Phys. 1999, 110.
40. CPMD, Copyright IBM Corp 1990-2006; Copyright MPI für Festkörperforschung Stuttgart 1997-2001.
41. Troullier, N.; Martins, J. L. Phys. Rev. B 1991, 43, 1993-2006.
42. Except noted otherwise all pseudopotentials were the ones provided in the PP-library of CPMD (www.cpmd.org).
43. Maurer, P.; Magistrate, A.; Rothlisberger, U. J. Phys. Chem. A 2004, 108, 11494.
44. Kleinman, L.; Bylander, D. M. Phys- Rev. Lett. 1982, 48, 1425-1428
45. Gossens, C.; Tavernelli, I.; Rothlisberger, U. Chimia 2005, 59, 81-84.
46. Colombo, M. C.; Gossens, C.; Tavernelli, I.; Rothlisberger, U. From Enzymatic Catalysis to Anticancer Drugs: QM/MM. Car-Parrinello Simulations of Biological Systems. In Modelling Molecular Structure and Reactivity in Biological Systems; Naidoo, K. J., Brady, J., Field, M., Gao, J., Hann, M., Eds.; Royal Society of Chemistry; Cambridge, U.K., 2006; Special Vol. WATOC 2005, pp 85.100.
47. Gossens, C.; Tavernelli, I.; Rothlisberger, U. J. Am. Chem. Soc. 2008, 130, 10921-10928.
48. Flükiger, P.; Lüthi, H. P.; Portmann, S.; Weber, J. MOLEKEL 4.0;Swiss Center for Scientific Computing: Manno, Switzerland, 2000.
49. Humphrey, W.; Dalke, A.; Schulten, K. J. Mol. Graph. 1996, 14, 33-38.
50. This distance is 0.4 Å shorter than in the TS (Figure 5) but allowed the reaction to occur spontaneously within the time scale of our simulation. Longer constrained distances did not yield a reaction on a picosecond timescale (e.g., 2.95 Å at 310-500 K during 2.7 ps), while shorter distances caused the aqua ligand to detach rapidly.
51. Deubel, D. V.; Lau, J. K.-C. Chem. Commun. 2006, 2451-2453.
52. Morris, R. E.; Aird, R. E.; Murdoch, P. d. S.; H; Chen, J. C.; Hughes, N. D.; Parsons, S.; Perkin, A.; Boyd, G.; Jodrell, D. I.; Sadler, P. J. J. Med. Chem. 2001, 44, 3616-3621.
53. Raber, J.; Zhu, C. B.; Eriksson, L. A. J. Phys. Chem. B 2005, 109, 11006.